Timil Patel, MD

@PamelaKunzMD @YaleMed @YaleCancer @ericwiner @ROYHERBST Congratulations!!

With gratitude and excitement, I am happy to share that I’ve been promoted to Professor of Medicine (Oncology). It's been a long journey since my white coat ceremony. @YaleMed @YaleCancer @ericwiner @royherbst 🧵1/6

The newly-established Raj and Indra Nooyi Cancer Research Fund will help @YaleSurgery researchers led by @MehraGolshan reduce the global burden of #breast #cancer through early detection and advanced #treatment strategies with reduced toxicity: brnw.ch/21wPLmV

.@LalehAmiri and @DrEricWiner moderate a special session @SABCSSanAntonio to better understand the process of @US_FDA @FDAOncology drug review and approval process. @SmilowCancer @YaleMed @YaleBreast

#OncTwitter fellows, hope to see you there! Apply by 12/4! #MedEd #regulatory

@pkluetz giving an @FDAOncology perspective on DCT and pragmatic trials on the heels of recent published FDA guidances @CancerResrch. Every trial can integrate pragmatic and DCT elements, and the degree would be context dependent on the disease setting & treatments involved.

Recently we welcomed more than 40 fellows to FDA—in collaboration with @ASCO—for an educational workshop, now in its 10th year. An additional almost 100 fellows joined virtually. What a great group! #OncEdFellows #OCEProjectSocrates #MedEd

FDA Oncology Center and other FDA staff as well as @DrCaliff_FDA celebrated Dr. Richard Pazdur’s ongoing 25 years of service at the agency during an FDA Fall Tailgating event on Oct. 17.

Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug - via @JCO_ASCO. Authors @GautamMehtaMD @realrickpazdur ascopubs.org/doi/full/10.12… #OCEPublications #OCEProjectConfirm

FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer without EGFR mutations or ALK rearrangements. fda.gov/drugs/resource… #OCENewsBurst #lcsm

FDA approves osimertinib for locally advanced, unresectable (stage III) non-small cell lung cancer following chemoradiation therapy. fda.gov/drugs/resource… #OCENewsBurst

Proud of the efforts of Project Asha “Quad Countries Launch Cancer Moonshot Initiative to Reduce the Burden of Cancer in the Indo-Pacific”. The power of leadership coming together to make a difference. @POTUS @narendramodi @PMOIndia whitehouse.gov/briefing-room/…

NEW 📣Final FDA Guidance on decentralized #clinicaltrials is out! Covers local labs, imaging, procedures; local healthcare providers; telehealth; informed consent; inv product delivery/accountability; & data mgmt. #MedTwitter #regulatory #DrugDevelopment fda.gov/regulatory-inf…

Its here! @US_FDA guidance on Conducting Clinical Trials With Decentralized Elements is out! Protocols should specify whether - Telehealth visits is appropriate - Local health care providers can conduct study visits fda.gov/regulatory-inf…

FDA approves lazertinib in combination with amivantamab-vmjw for locally advanced or metastatic non-small lung cancer with specific EGFR mutations. fda.gov/drugs/resource… #OCENewsBurst #lcsm

A @CCR_AACR article highlights how the FDA-AACR Oncology Educational Fellowship helped four alumni develop their career trajectories. Applications for the next class of fellows are open through Aug 1. Learn more: bit.ly/3SljsIG #AACRSciencePolicy @timilpatel @HadidiSamer

Beginning tomorrow, the Cancer Cabinet that @POTUS created to end cancer as we know it - will host a series of virtual conversations highlighting key actions driving progress on priorities for the #BidenCancerMoonshot. Join us! whitehouse.gov/cancermoonshot…

Career Development Beyond the @FDAOncology-AACR Oncology Educational Fellowship @CCR_AACR @timilpatel @drjennifergao oncodaily.com/95185.html #Cancer #CancerResearch #FDAOncology #AACR #OncoDaily #Oncology

Check👇 Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship @HemOncFellows @FDAOncology @timilpatel @drjennifergao @ChrisChenMD Yasmin Kadry @UAMSMyeloma @CCR_AACR ➡️ aacrjournals.org/clincancerres/… A great program, highly recommended

Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship - via @CCR_AACR ✔️ Transformative experience ✔️ Regulatory deep dive ✔️ Mock ODAC 💯 Unique opportunity! aacrjournals.org/clincancerres/… @timilpatel @drjennifergao #MedEd #OCEProjectSocrates

Online First: Effect of #ProjectOrbis participation by the Swiss regulator @Swissmedic_ on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis #cancerdrugs thelancet.com/journals/lanon…